ICMR Launches Biomedical Technology Transfer Platform to Fast-Track Indigenous Healthcare Innovation
Advertisement
The initiative is being positioned as one of India’s greatest structured efforts focused on biomedical technology transfer, IP facilitation, and healthcare innovation partnerships.
The Indian Council of Medical Research (ICMR) has launched a structured Biomedical Technology Transfer Platform under its Medical Innovations Patent Mitra initiative to strengthen Healthcare Innovation in India by enabling faster industry adoption of indigenous medical technologies, diagnostics, vaccines, and biomedical research solutions.
The initiative is being positioned as one of India’s greatest structured efforts focused on biomedical technology transfer, intellectual property facilitation, and healthcare innovation partnerships.
Union Minister of State for Ayush and Health and Family Welfare, Prataprao Ganpatrao Jadhav, said, “This initiative marks a decisive step in connecting Indian science with industry, ensuring that innovations developed in our laboratories translate into technologies that strengthen public health and advance Viksit Bharat.”
“India is moving from being a consumer of health technologies to becoming a global source of affordable and innovative healthcare solutions, powered by institutions like ICMR and strong industry partnerships,” he added.
The platform was introduced during a recent event organized by the ICMR under the MoHFW in New Delhi.
During the event, ICMR transferred 41 public health technologies developed by its institutes and innovators to industry partners for further development, manufacturing, and commercialization.
The technologies span several critical healthcare areas, including advanced diagnostics, vaccines, medical devices, and biomedical solutions intended to address major public health challenges.
Among the technologies transferred were glycoconjugate and recombinant vaccines developed for Typhoid and Paratyphoid prevention, along with diagnostic technologies related to Tuberculosis, Japanese Encephalitis, and Mpox.
In a first-of-its-kind move, ICMR also enabled the transfer of inactivated Kyasanur Forest Disease (KFD) and Chandipura virus biomaterials to industry partners.
The development is expected to support vaccine research, biomedical manufacturing, and advanced infectious disease studies within India’s growing biotechnology ecosystem.
The event also saw the release of the “Indian Biomedical Patent Landscape Report” and the “Technology Compendium,” both expected to support India’s evolving biomedical intellectual property and Healthcare Innovation ecosystem.
Industry experts believe the Biomedical Technology Transfer Platform could become a long-term mechanism for accelerating translational research, strengthening public-private partnerships, and positioning India as a global hub for affordable healthcare technologies.
Stay tuned for more such updates on Digital Health News
